Take advantage of the Early Bird Registration Fee (until January 31, 2027)
REGISTER NOW

>>> Organizing Office
  

Dear Colleagues, Dear Friends,

We are happy to invite you to the 20th anniversary of the international symposium

ACUTE LEUKEMIAS XX (ISALXX)

the premier hematology event in spring 2027 for all healthcare professionals active in the field of acute leukemias.

This symposium has a more than 40-year tradition and is considered as one of the most valuable meetings in acute leukemias. Don’t miss this opportunity to learn about the latest advances in pre-clinical and clinical leukemia research from our panel of top international experts. We also invite you to contribute your own scientific abstract, highlighting your most recent findings and updates.

The symposium is taking place under the new chairmanship of Karsten Spiekermann and Klaus Metzeler together with our honorary chairman, Wolfgang Hiddemann, in Munich from Sunday, March 14 until Wednesday, March 17, 2027, in-person only, and is addressing all healthcare professionals active in the field of acute leukemias.

The focus of the symposium will be on the following key areas:

  • Biology of Acute Leukemias
  • Genetic and Molecular Characterization of AML
  • Novel Markers for Diagnosis and Prognosis
  • Novel Approaches and Targeted Therapies in AML
  • Risk-adapted Therapy of AML and APL
  • MRD in Acute Leukemias: Methods and Clinical Applications
  • Immunotherapy for Acute Leukemias, including Transplantation
  • ALL: Biology and Treatment Strategies

These areas will be covered by invited speakers representing the leading institutions and research groups around the world. As always, there will be no parallel sessions, ensuring participants can attend all lectures without overlap.

Satellite Symposia and Meet-the-Expert Sessions will provide additional opportunities to discuss advances and perspectives of basic science and new treatment strategies.

Two sessions for unsolicited abstracts– a poster session and an oral session showcasing the best submitted abstracts (“Best of Free Contributions”) – will additionally allow all participants to present their own research data and discuss their findings with the most renowned scientists and researchers in the field of acute leukemias worldwide.

Don´t miss this unique opportunity to discover and discuss cutting-edge research and meet experts, colleagues and friends.

We look forward to welcoming you in-person in Munich in March 2027.

Yours,

 

Prof. Dr. med.
Karsten Spiekermann
Chairman ISALXX
 

Prof. Dr. med.
Klaus Metzeler
Chairman ISALXX
 

Prof. Dr. med.
Wolfgang Hiddemann
Honorary Chairman ISALXX